Is abdominal adiposity associated with elevated C-reactive protein independent of BMI in healthy nonobese people?
In nonobese people, moderate abdominal adiposity is associated with markers of subclinical inflammation independent of BMI.
Therapeutic approaches aimed at restoring a physiological pattern of insulin secretion could prove effective in reducing postprandial glucose excursions particularly in the early stage of Type II diabetes.